SARS-CoV-2 evolution from the BA.2.86 to JN.1 variants: unexpected consequences

SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies

Christopher O. Barnes, Claudia A. Jette, Morgan E. Abernathy et al. · Nature · 2020 · 1.9K citations · Full text

Life Sciences, Immunology, Infectious Diseases +16

Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution

Yunlong Cao, Fanchong Jian, Jing Wang et al. · Nature · 2022 · 703 citations · Full text

Life Sciences, Immunology, Infectious Diseases +14

Antigenicity and receptor affinity of SARS-CoV-2 BA.2.86 spike

Qian Wang, Yicheng Guo, Liyuan Liu et al. · Nature · 2023 · 206 citations · Full text

Life Sciences, Immunology, Infectious Diseases +13

Immune evasion, infectivity, and fusogenicity of SARS-CoV-2 BA.2.86 and FLip variants

Panke Qu, Kai Xu, Julia N. Faraone et al. · Cell · 2024 · 159 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

SARS-CoV-2 BA.2.86 enters lung cells and evades neutralizing antibodies with high efficiency

Lu Zhang, Amy Kempf, Inga Nehlmeier et al. · Cell · 2024 · 121 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +7